Background: Previous studies have reported varying outcomes in pts with ACS and non-obstructive CAD. Whether non-obstructive CAD confers the same prognosis in pts with unstable angina (UA) compared to those with NSTEMI is unknown. Methods: Of 6,921 pts with ACS undergoing an early invasive strategy in whom quantitative angiography of the entire coronary artery tree was performed in the ACUITY trial, those with a maximum stenosis of Ͻ50 % in all coronary arteries were defined as non-obstructive CAD. Baseline features and outcomes through 1-year follow-up in such pts treated without revascularization were examined according to whether they presented with UA (CKMB or troponin Ϫ) or NSTEMI (CKMB or troponin ϩ). Results: Non-obstructive CAD was present in 955 pts (14.4%) treated conservatively; 603 (63.1%) had UA whereas 352 (26.9%) had NSTEMI. Compared to pts with UA, pts with NSTEMI were paradoxically less likely to require insulin; have hypertension or hyperlipidemia; have had a prior MI or a previous PTCA; or present with ST-segment deviation Ն 1mm. Pts with NSTEMI were more likely to present at low to intermediate TIMI risk. A similar percentage of pts with NSTEMI and UA received aspirin and/or a thienopyridine on discharge. Pts with NSTEMI were more than twice as likely to die or have an MI by 1 year than pts with UA, whereas unplanned revascularization was more common in those with UA (Table) . Conclusions: Among ACS pts with non-obstructive CAD treated conservatively in the ACUITY trial, despite having fewer cardiovascular risk factors at baseline, similar use of anti-platelet therapies and requiring fewer revascularization procedures, pts with NSTEMI were more than twice as likely as those with UA to die or have a MI by 1 year. Novel approaches are required for pts with NSTEMI and non-obstructive CAD. 
Background: Microvascular obstruction (MVO), visualized with Cardiovascular Magnetic Resonance (CMR) imaging as a lack of Gadolinium-contrast wash-in, is a common finding after a revascularized ST-elevation Myocardial Infarction (STEMI). Its presence is associated with increased long-term morbidity and mortality. Using a porcine model of coronary occlusion-reperfusion we correlated CMR-determined MVO with histopathological findings and compared this to CMR data performed in STEMI-patients. Methods: In 8 Yorkshire swine, the circumflex coronary artery was occluded for 75 minutes by balloon catheter. After 7 days, CMR with cine imaging, T2-weighted turbospinecho and Late Gadolinium Enhancement was performed to assess function, infarct size, and the presence of intramyocardial hemorrhage (IMH) and/or MVO. CMR findings were compared to histological findings after phosphotungstic acid-hematoxylin and anti-CD31/Hematoxylin staining. CMR and histological findings were then compared to CMR findings in 8 consecutive PCI-treated STEMI-patients. Results: In the porcine model, the infarct core contained extensive necrosis, disruption of microvasculature and extravasation of erythrocytes. The surrounding -Gadoliniumenhanced-area contained granulation tissue, leukocyte infiltration and necrosis with morphological intact microvessels containing microthrombi, but without extravasation of erythrocytes. Areas with IMH (median size 1. 
University of Debrecen, Debrecen, Hungary
Background: In the Syntax study the Leaman weighing factor is used for the evaluation of the left ventricular areas affected by the lesion. Taking the two main coronary circulation systems the scoring system orders predefined points to the segments of the coronary artery. Methods: The coronary angiograms were analyzed retrospectively from the data of 19 patients deceased from ST-elevation myocardial infarction. The Leaman factor and the result of an individualized coronary angiographic area at risk assessment called Holistic Coronary Care (HCC) software were compared with the extent of infarction found by the autopsy. With the consideration of the complementary distribution of the left anterior descending artery and posterior descendent branch as well as the right and the left coronary artery there were 3x4ϭ12 circulation types registered in the HCC. The size of the supplied area by the software (standard 17-segment model) was compared to the size of the involved area according to the Leaman weighing factor.
Results:
Multivariate regression analysis showed significant correlation between the extension of the infarction detected by autopsy and the HCC segment number (rϭ0.78, pϭ0.0002), while there was no significant correlation with the Leaman factor (r ϭ 0.46, p ϭ 0.08). Conclusions: With defining the individual circulation types with the HCC software it is possible to determine the left ventricular segments related to the lesion with better correlation than by Leaman weighing score. Background: Left ventricular (LV) dysfunction and multi-vessel disease (MVD) have been associated with greater mortality after ST-segment elevation myocardial infarction. We sought to evaluate their impact in patients treated with primary percutaneous coronary intervention (PCI). Methods: Patients from the HORIZONS-AMI trial treated with primary PCI in whom baseline left ventricular ejection fraction (LVEF) was assessed by left ventriculography were included in this study. Early and late (3-year) outcomes were examined in groups of patients with reduced (Ͻ40%) and preserved (Ն40%) LVEF, further stratified by the presence of MVD. Results: 2,430 patients were included. Patients with reduced LVEF were older, were more likely to be female, have a prior history of MI, PCI and congestive heart failure (CHF), and present in CHF. 03 [3.37,7 .50]; pϽ0.0001). Among patients with LVEF Ͻ30% (nϭ45), 30%-40% (nϭ157), 40%-50% (nϭ373), 50%-60% (nϭ659) and Ն60% (nϭ1196), the 3-year mortality was 29.4%, 13.5%, 6.4%, 3.8% and 2.9% respectively (p for trend Ͻ0.0001). MVD was associated with greater mortality in patients with preserved but not reduced LVEF. By multivariable analysis, LV dysfunction was the strongest predictor of 30-day and 3-year mortality. In the contemporary era, the presence of baseline LV dysfunction in patients undergoing primary PCI is a powerful predictor of early and late mortality, regardless of the extent of coronary artery disease.
TCT-479

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial
TCT-480
Outcomes 
